Table 3.
Infection-related clinical syndromes commonly seen in patients with solid tumors
| Clinical syndrome | Comments |
|---|---|
| Post-obstructive pneumonia | Frequent in patients with primary or metastatic lung lesions. Sometimes the initial manifestation of malignancy. Complications include lung abscess, fistula formation, or empyema. Treatment failures common |
| Obstructive uropathy | Common in patients with genitourinary and prostatic tumors. Complicated urinary tract infections and multidrug-resistant organisms are frequent |
| Reactivation of viral infections | Hepatitis B virus and hepatitis C virus, usually following chemotherapy or immunosuppressive therapy. Screening for all patients scheduled to receive chemotherapy is recommended as is HBV prophylaxis for patients with HBV infection |
| Clostridium difficile associated disease | Multiple risk factors (antibiotics, chemotherapy, local anatomical factors). Recurrent infections/relapses common. Newer therapies (fidaxomicin, fecal microbiota transplantation) have been developed |
| Neutropenic enterocolitis | Associated with taxanes (docetaxel and paclitaxel), vinorelbine, and other agents producing severe mucositis |